Explore how AI, gene editing, and digital tools are driving a tech-driven future in pharma, reshaping drug discovery, clinical trials, and manufacturing.
Block Inc. stock drop of 20% reflects fintech struggles, driven by weak Q1 earnings, stagnant Cash App growth, and reduced full-year guidance.
Discover how the coverage-gap score reveals companies with few equity analysts vs market cap, highlighting risks, opportunities, and undervalued stocks in 2025.
Discover the 5 top pharma stocks to watch in 2025. Gain equity analysis insights on Eli Lilly, J&J, Merck, Thermo-Fisher, and AbbVie for strong growth.
The rise of green energy: how renewable energy is transforming the tech industry in 2025 through AI, data centers, and innovative energy solutions.
Stem-cell research resurgence in 2025 is fueled by regulatory reforms, political advocacy, and investments, with biotech firms advancing groundbreaking therapies.
European tech startups are listing on U.S. stock markets for deeper capital, higher valuations, and investor demand, raising concerns for European markets.
Private equity in European tech is driving recovery in 2025 through innovation, ESG investments, and cross-border deals, overcoming 2024's challenges.
Blackstone's $24B AirTrunk acquisition boosts digital infrastructure, meeting AI and cloud computing demands while positioning Asia-Pacific as a tech innovation hub.
Private equity in information technology drives innovation in 2025, shaping M&A trends with AI, SaaS, and digital transformation as key focus areas.